230 related articles for article (PubMed ID: 17986216)
1. Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors.
Wu DF; Yang LQ; Goschke A; Stumm R; Brandenburg LO; Liang YJ; Höllt V; Koch T
J Neurochem; 2008 Feb; 104(4):1132-43. PubMed ID: 17986216
[TBL] [Abstract][Full Text] [Related]
2. Internalization and recycling of the CB1 cannabinoid receptor.
Hsieh C; Brown S; Derleth C; Mackie K
J Neurochem; 1999 Aug; 73(2):493-501. PubMed ID: 10428044
[TBL] [Abstract][Full Text] [Related]
3. Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor.
Gyombolai P; Boros E; Hunyady L; Turu G
Mol Cell Endocrinol; 2013 Jun; 372(1-2):116-27. PubMed ID: 23541635
[TBL] [Abstract][Full Text] [Related]
4. [The synthetic cannabinoid analog WIN 55,212-2 potentiates the amplitudes of glycine-activated currents].
Iatsenko NM; Tsintsadze TSh; Lozova NO
Fiziol Zh (1994); 2007; 53(3):31-7. PubMed ID: 17725041
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
[TBL] [Abstract][Full Text] [Related]
8. Multiple mechanisms of CB1 cannabinoid receptors regulation.
Keren O; Sarne Y
Brain Res; 2003 Aug; 980(2):197-205. PubMed ID: 12867259
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
11. A real time screening assay for cannabinoid CB1 receptor-mediated signaling.
Andersen HK; Piroli GG; Walsh KB
J Pharmacol Toxicol Methods; 2018; 94(Pt 1):44-49. PubMed ID: 29730318
[TBL] [Abstract][Full Text] [Related]
12. Role of phospholipase D2 in the agonist-induced and constitutive endocytosis of G-protein coupled receptors.
Koch T; Wu DF; Yang LQ; Brandenburg LO; Höllt V
J Neurochem; 2006 Apr; 97(2):365-72. PubMed ID: 16539674
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor interacting protein suppresses agonist-driven CB
Blume LC; Leone-Kabler S; Luessen DJ; Marrs GS; Lyons E; Bass CE; Chen R; Selley DE; Howlett AC
J Neurochem; 2016 Nov; 139(3):396-407. PubMed ID: 27513693
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids facilitate the swallowing reflex elicited by the superior laryngeal nerve stimulation in rats.
Mostafeezur RM; Zakir HM; Takatsuji H; Yamada Y; Yamamura K; Kitagawa J
PLoS One; 2012; 7(11):e50703. PubMed ID: 23209814
[TBL] [Abstract][Full Text] [Related]
17. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1.
Martini L; Thompson D; Kharazia V; Whistler JL
Neuropsychopharmacology; 2010 May; 35(6):1363-73. PubMed ID: 20164830
[TBL] [Abstract][Full Text] [Related]
19. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
